Trisalus Life Sciences Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Trisalus Life Sciences Inc 's ROA in the second quarter of 2026?
Trisalus Life Sciences Inc recorded a cumulative net loss of $-47 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -91.14%.

However, within the Healthcare sector 717 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4265, from total ROA ranking in the first quarter of 2026 at 5129.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	55.79 %	147.96 %	55.86 %	32.21 %	23.6 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-47	-46	-58	-58	-31
Return On Assets (TTM)	-91.14 %	-100.33 %	-164.55 %	-181.93 %	-104.86 %
TLSI's Total Ranking	# 4265	# 5129	# 4573	# 4463	# 4510
Total Assets (TTM) in million	62	71	35	36	40
Seq. Total Assets Change	-12.02 %	100.9 %	-2.74 %	-9.37 %	40.03 %
Seq. Net Income Change	-	-	-	-	-

TLSI's 5 Years Annual ROA >> Back to TLSI Management Effectiveness >> Compare TLSI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 168
Sector	# 718
Overall	# 4184

Return On Assets Statistics
High	Average	Low
3.98 %	-125.73 %	-397.69 %
(Jun 30 2022)		(Mar 31 2024)

Financial Statements
Trisalus Life Sciences Inc 's Assets	$ 62 million	TLSI's Balance sheet
Trisalus Life Sciences Inc 's Income	$ -9 million	Quarterly TLSI's Income Statement
TLSI's Income by Division		See TLSI's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	55.86 %	-9.28 %	23.78 %	-91.94 %	-0.59 %
Total Assets in million	35	23	25	20	251
Y / Y Net Income Change	-	-	-	16.19 %	-
Net Income in million	-58	-30	-62	6	5
Annual Return On Assets	-163.43 %	-132.54 %	-248.19 %	27.44 %	1.9 %

TLSI's 5 Years Annual ROA >> Back to TLSI Management Effectiveness >> Compare TLSI ROA to its Competitors

More Return On Assets Ratios
TLSI's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TLSI's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TLSI's Competitors
Subscribers only: Roa for Trisalus Life Sciences Inc 's Suppliers
Subscribers only: Return On Assets for TLSI's Customers

You may also want to know
TLSI's Roi	TLSI's Inventory Turnover Ratio	TLSI's Growth Rates	TLSI's Dividend Comparisons
	TLSI's Profitability Ratios	TLSI's Asset Turnover Ratio	TLSI's Dividend Growth
TLSI's Roe	TLSI's Valuation Ratios	TLSI's Financial Strength Ratios	TLSI's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-08T22:36:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.